A cross-sectional survey of the prevalence and patterns of using cannabis as a sleep aid in Canadian cancer survivors.
Canada
Cancer
Cannabis
Insomnia
Sleep
Journal
Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557
Informations de publication
Date de publication:
14 Oct 2023
14 Oct 2023
Historique:
received:
11
08
2023
accepted:
22
09
2023
medline:
15
10
2023
pubmed:
15
10
2023
entrez:
14
10
2023
Statut:
aheadofprint
Résumé
Poor sleep is one of the most common side effects of cancer. It can persist for years beyond treatment and negatively impact quality of life and health. Cannabis is increasingly used to manage cancer treatment-related symptoms, including sleep. This study investigated the use and perceived effects of cannabis as a sleep aid in Canadian cancer survivors. Adult Canadian cancer survivors (N = 1464) were recruited via the Angus Reid Institute and completed an online, cross-sectional survey including the Insomnia Severity Index and questions about cannabis use for sleep. Standard descriptive statistics, such as means, standard deviations, and ranges were produced for measured variables to assess the ways cancer survivors use cannabis for sleep. Frequencies were tabulated for categorical and ordinal variables. On average, participants (M Given the prevalence and potential impact, research is needed to examine the actual efficacy of cannabis as a sleep aid. It is important that cancer survivors have information on methods to help their sleep to avoid impairments to quality of life and health.
Identifiants
pubmed: 37837502
doi: 10.1007/s11764-023-01474-2
pii: 10.1007/s11764-023-01474-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Canadian Cancer Society Research Institute
ID : 707146
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Nunn CL, Samson DR, Krystal AD. Shining evolutionary light on human sleep and sleep disorders. Evol Med Public Health. 2016;2016(1):227–43.
pubmed: 27470330
pmcid: 4972941
doi: 10.1093/emph/eow018
Hung CM, et al. Risk of dementia in patients with primary insomnia: a nationwide population-based case-control study. BMC Psychiatry. 2018;18(1):38.
pubmed: 29415688
pmcid: 5804010
doi: 10.1186/s12888-018-1623-0
Bertisch SM et al. Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: sleep heart health study. Sleep. 2018;41(6):zsy047.
Bin YS, Marshall NS, Glozier N. The burden of insomnia on individual function and healthcare consumption in Australia. Aust N Z J Public Health. 2012;36(5):462–8.
pubmed: 23025369
doi: 10.1111/j.1753-6405.2012.00845.x
Lallukka T, et al. Joint associations of sleep duration and insomnia symptoms with subsequent sickness absence: the Helsinki Health Study. Scand J Public Health. 2013;41(5):516–23.
pubmed: 23520224
doi: 10.1177/1403494813481647
APA. The diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
Mullan F. Seasons of survival: reflections of a physician with cancer. N Engl J Med. 1985;313(4):270–3.
pubmed: 4010738
doi: 10.1056/NEJM198507253130421
Al Maqbali M, et al. Prevalence of sleep disturbance in patients with cancer: a systematic review and meta-analysis. Clin Nurs Res. 2022;31(6):1107–23.
pubmed: 35484919
pmcid: 9266067
doi: 10.1177/10547738221092146
Harrold EC, et al. Prevalence of insomnia in an oncology patient population: an Irish tertiary referral center experience. J Natl Compr Canc Netw. 2020;18(12):1623–30.
pubmed: 33285516
pmcid: 9337980
doi: 10.6004/jnccn.2020.7611
Palesh O, et al. Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer. Nat Sci Sleep. 2012;4:151–62.
pubmed: 23486503
pmcid: 3593248
doi: 10.2147/NSS.S18895
Reynolds-Cowie P, Fleming L. Living with persistent insomnia after cancer: a qualitative analysis of impact and management. Br J Health Psychol. 2021;26(1):33–49.
pubmed: 32558129
doi: 10.1111/bjhp.12446
Strollo SE, et al. Cancer-related problems, sleep quality, and sleep disturbance among long-term cancer survivors at 9-years post diagnosis. Sleep Med. 2020;65:177–85.
pubmed: 32029206
doi: 10.1016/j.sleep.2019.10.008
Lis CG, Gupta D, Grutsch JF. The relationship between insomnia and patient satisfaction with quality of life in cancer. Support Care Cancer. 2008;16(3):261–6.
pubmed: 17684773
doi: 10.1007/s00520-007-0314-z
Colten HR, Altevogt BM, I.o.M. Sleep disorders and sleep deprivation: an unmet public health problem. Washington: National Academics Press; 2006.
Zhou ES, et al. Cancer patient’s attitudes of using medicinal cannabis for sleep. J Psychosocial Oncolocy. 2021;40(3):397–403.
doi: 10.1080/07347332.2021.1910396
Rosenberg R, Citrome L, Drake CL. Advances in the treatment of chronic insomnia: a narrative review of new nonpharmacologic and pharmacologic therapies. Neuropsychiatr Dis Treat. 2021;17:2549–66.
pubmed: 34393484
pmcid: 8354724
doi: 10.2147/NDT.S297504
Brandt J, Leong C. Benzodiazepines and Z-Drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs R D. 2017;17(4):493–507.
pubmed: 28865038
pmcid: 5694420
doi: 10.1007/s40268-017-0207-7
Jacobs GD, et al. Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med. 2004;164(17):1888–96.
pubmed: 15451764
doi: 10.1001/archinte.164.17.1888
Suraev A, et al. Cannabidiol (CBD) and Delta(9)-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial. BMJ Open. 2020;10(5):e034421.
pubmed: 32430450
pmcid: 7239553
doi: 10.1136/bmjopen-2019-034421
Qaseem A, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125–33.
pubmed: 27136449
doi: 10.7326/M15-2175
Williams J, et al. Cognitive behavioral treatment of insomnia. Chest. 2013;143(2):554–65.
pubmed: 23381322
pmcid: 4694188
doi: 10.1378/chest.12-0731
Squires LR, et al. Systematic review and meta-analysis of cognitive-behavioural therapy for insomnia on subjective and actigraphy-measured sleep and comorbid symptoms in cancer survivors. Sleep Med Rev. 2022;63:101615.
pubmed: 35303692
doi: 10.1016/j.smrv.2022.101615
Howell D, et al. A pan-canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Curr Oncol. 2013;20(3):e233-46.
pubmed: 23737693
pmcid: 3671030
doi: 10.3747/co.20.1302
Zhou ES, et al. Evaluation and treatment of insomnia in adult cancer survivorship programs. J Cancer Surviv. 2017;11(1):74–9.
pubmed: 27495283
doi: 10.1007/s11764-016-0564-1
Thomas A, et al. Where are the behavioral sleep medicine providers and where are they needed? A geographic assessment. Behav Sleep Med. 2016;14(6):687–98.
pubmed: 27159249
pmcid: 5070478
doi: 10.1080/15402002.2016.1173551
Cheung JMY, et al. To drug or not to drug: a qualitative study of patients’ decision-making processes for managing insomnia. Behav Sleep Med. 2018;16(1):1–26.
pubmed: 27191585
doi: 10.1080/15402002.2016.1163702
Zachariae R, et al. Internet-delivered cognitive-behavioral therapy for insomnia in breast cancer survivors: a randomized controlled trial. J Natl Cancer Inst. 2018;110(8):880–7.
pubmed: 29471478
pmcid: 6093474
doi: 10.1093/jnci/djx293
Zhou ES, Recklitis CJ. Internet-delivered insomnia intervention improves sleep and quality of life for adolescent and young adult cancer survivors. Pediatr Blood Cancer. 2020;67(9):e28506.
pubmed: 32568460
doi: 10.1002/pbc.28506
Amidi A, et al. Changes in sleep following internet-delivered cognitive-behavioral therapy for insomnia in women treated for breast cancer: a 3-year follow-up assessment. Sleep Med. 2022;96:35–41.
pubmed: 35594778
doi: 10.1016/j.sleep.2022.04.020
Choi S, Huang BC, Gamaldo CE. Therapeutic uses of cannabis on sleep disorders and related conditions. J Clin Neurophysiol. 2020;37(1):39–49.
pubmed: 31895189
doi: 10.1097/WNP.0000000000000617
Andre CM, Hausman JF, Guerriero G. Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci. 2016;7:19.
pubmed: 26870049
pmcid: 4740396
doi: 10.3389/fpls.2016.00019
Kesner AJ, Lovinger DM. Cannabinoids, endocannabinoids and sleep. Front Mol Neurosci. 2020;13:125.
pubmed: 32774241
pmcid: 7388834
doi: 10.3389/fnmol.2020.00125
Hawley P, Gobbo M, Afghari N. The impact of legalization of access to recreational cannabis on Canadian medical users with cancer. BMC Health Serv Res. 2020;20(1):977.
pubmed: 33109169
pmcid: 7590602
doi: 10.1186/s12913-020-05756-8
Webster EM, et al. Prescribed medical cannabis in women with gynecologic malignancies: a single-institution survey-based study. Gynecol Oncol Rep. 2020;34:100667.
pubmed: 33204797
pmcid: 7653050
doi: 10.1016/j.gore.2020.100667
Abdel-Rahman O. Cannabis use among canadian adults with cancer (2007–2016): results from a national survey. Expert Rev Pharmacoecon Outcomes Res. 2021;21(5):1025–9.
pubmed: 33216657
doi: 10.1080/14737167.2021.1854735
Martell K, et al. Rates of cannabis use in patients with cancer. Curr Oncol. 2018;25(3):219–25.
pubmed: 29962840
pmcid: 6023560
doi: 10.3747/co.25.3983
Moltke J, Hindocha C. Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems. J Cannabis Res. 2021;3(1):5.
pubmed: 33602344
pmcid: 7893882
doi: 10.1186/s42238-021-00061-5
Babson KA, Sottile J, Morabito D. Cannabis, cannabinoids, and sleep: a review of the literature. Curr Psychiatry Rep. 2017;19(4):23.
pubmed: 28349316
doi: 10.1007/s11920-017-0775-9
De Feo G, et al. Multinational association of supportive care in cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression. Support Care Cancer. 2023;31(3):176.
pubmed: 36809575
doi: 10.1007/s00520-023-07628-3
Edwards D, Filbey FM. Are sweet dreams made of these? Understanding the relationship between sleep and cannabis use. Cannabis Cannabinoid Res. 2021;6(6):462–73.
pubmed: 34143657
pmcid: 8713269
doi: 10.1089/can.2020.0174
McLennan A, et al. Health care provider preferences for, and barriers to, cannabis use in cancer care. Curr Oncol. 2020;27(2):e199–205.
pubmed: 32489269
pmcid: 7253742
doi: 10.3747/co.27.5615
Donovan KA, et al. Cannabis consumption in young adults with cancer: descriptive study. BMJ Support Palliat Care. 2022. https://doi.org/10.1136/bmjspcare-2021-003353 .
Walsh JH et al. Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo. Sleep. 2021;44(11):zsab149.
Kuhathasan N, et al. The use of cannabinoids for insomnia in daily life: naturalistic study. J Med Internet Res. 2021;23(10):e25730.
pubmed: 34704957
pmcid: 8581757
doi: 10.2196/25730
Pivik RT, et al. Delta-9-tetrahydrocannabinol and synhexl: effects on human sleep patterns. Clin Pharmacol Ther. 1972;13(3):426–35.
pubmed: 4337346
doi: 10.1002/cpt1972133426
Suraev AS, et al. Cannabinoid therapies in the management of sleep disorders: a systematic review of preclinical and clinical studies. Sleep Med Rev. 2020;53:101339.
pubmed: 32603954
doi: 10.1016/j.smrv.2020.101339
Belendiuk KA, et al. Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users. Addict Behav. 2015;50:178–81.
pubmed: 26151582
doi: 10.1016/j.addbeh.2015.06.032
Barratt ES, Beaver W, White R. The effects of marijuana on human sleep patterns. Biol Psychiatry. 1974;8(1):47–54.
pubmed: 4361028
Fallon MT, et al. Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies. Br J Pain. 2017;11(3):119–33.
pubmed: 28785408
pmcid: 5521351
doi: 10.1177/2049463717710042
Zylla DM, et al. A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction. Support Care Cancer. 2021;29(12):7471–8.
pubmed: 34085149
doi: 10.1007/s00520-021-06301-x
von Elm E, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7.
doi: 10.1016/S0140-6736(07)61602-X
Morin CM. Insomnia: Psychological Assessment and Management. New York: Guilford; 1993.
Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297–307.
pubmed: 11438246
doi: 10.1016/S1389-9457(00)00065-4
Morin CM, et al. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601–8.
pubmed: 21532953
pmcid: 3079939
doi: 10.1093/sleep/34.5.601
Savard J, et al. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol. 2005;23(25):6083–96.
pubmed: 16135475
doi: 10.1200/JCO.2005.09.548
Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989;262(11):1479–84.
pubmed: 2769898
doi: 10.1001/jama.1989.03430110069030
Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327–60.
pubmed: 12648025
doi: 10.2165/00003088-200342040-00003
Eadie L, et al. Duration of neurocognitive impairment with medical cannabis use: a scoping review. Front Psychiatry. 2021;12:638962.
pubmed: 33790818
pmcid: 8006301
doi: 10.3389/fpsyt.2021.638962
Velzeboer R et al. Cannabis dosing and administration for sleep: a systematic review. Sleep. 2022;45(11):zsac218.
Arboleda MF, et al. Medical cannabis in supportive cancer care: lessons from Canada. Support Care Cancer. 2020;28(7):2999–3001.
pubmed: 32172409
doi: 10.1007/s00520-020-05403-2